CLINICAL_TRIALS
trial_result
· 2020-09-09
Clinical Trial Update: FIasp® vs. Novolog® in Type 1 Diabetics Using 670G Medtronic Pump [Phase 3]
Summary
Phase 3 trial comparing FIasp to Novolog in type 1 diabetes patients using a 670G insulin pump has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Texas Diabetes & Endocrinology, P.A. | Conditions: Type 1 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2020-09-09